NCT03186248

Brief Summary

Aim of this study is to compare the outcomes of a short esophageal myotomy extending from 3 cm cephalad to the EGJ, to 3 cm distal to it with a long esophageal myotomy with an additional proximal extension (at least 6 cm cephalad to the EGJ, to 3 cm distal) for POEM procedures. Principle of POEM is to reduce pressure gradient across LES by Myotomy. Hypothesis is that performing short myotomy will result in similar efficacy in achalasia cardia while reducing the total time taken for the procedure and ultimately will result in less complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
71

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

June 9, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 14, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
Last Updated

December 30, 2019

Status Verified

December 1, 2019

Enrollment Period

9 months

First QC Date

June 9, 2017

Last Update Submit

December 25, 2019

Conditions

Keywords

Achalasia cardiamyotomyPer oral endoscopic myotomylaparoscopic fundoplication

Outcome Measures

Primary Outcomes (1)

  • Comparison of clinical efficacy between short and long myotomy groups

    Clinical success defined as Eckardt score≤3 compared between the two groups

    1 year

Secondary Outcomes (6)

  • Difference in operating time between short and long esophageal myotomy during POEM

    Intra-opeartive

  • Intraoperative adverse events

    At the time of index procedure

  • LES pressure reduction

    1 and 3 months

  • Comparison of changes in Eckardt score

    1, 3 and 12 months

  • Comparison of gastroesophageal Reflux disease (GERD) Rates

    3 months

  • +1 more secondary outcomes

Study Arms (2)

Short myotomy

EXPERIMENTAL

Per oral endoscopic myotomy extending from 3 cm cephalad to 3 cm distal to EGJ

Procedure: Per oral endoscopic myotomy

Long myotomy

ACTIVE COMPARATOR

Per oral endoscopic myotomy extending from 6-8cm cephalad to and 3 cm distal to EGJ.

Procedure: Per oral endoscopic myotomy

Interventions

General anesthesia will be administered and an esophagogastroduodenoscopy will be performed. Mucosal incision proximal to the gastroesophageal junction (GEJ) will be identified depending on short or long myotomy. A 1.5- to 2-cm mucosal incision will be performed after raising a submucosal wheal. The endoscope will be inserted to create a submucosal tunnel with a combination of blunt dissection, carbon dioxide insufflation, hydro dissection and careful electrocautery. The tunnel will be extended past the GEJ, 3 cm onto the gastric cardia. after myotomy, the mucosal incision will then be closed using standard endoscopic clips.

Long myotomyShort myotomy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 1 and 2 achalasia with eckerd score \>3 (0-12 scale achalasia) -.
  • Age 18-75 years.
  • Treatment naïve or history of pneumatic balloon dilatation.
  • Willing and able to comply with the study procedures and provide written informed consent form to participate in the study.

You may not qualify if:

  • Type 3 achalasia cardia or any other esophageal motility disorder
  • Previous surgery of the esophagus or stomach
  • Active severe esophagitis
  • Large lower esophageal diverticula
  • Large \> 3cm hiatal hernia
  • Sigmoid esophagus
  • Known gastroesophageal malignancy
  • Inability to tolerate sedated upper endoscopy due to cardiopulmonary instability, severe pulmonary disease or other contraindication to endoscopy
  • Cirrhosis with portal hypertension, varices, and/or ascites

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohan Ramchandani

Hyderabad, Telangana, 500082, India

Location

MeSH Terms

Conditions

Esophageal Achalasia

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • mahiboob sayyed, MD

    Asian Institute of Gastroenterology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blind randomized clinical trial
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Double blind randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 9, 2017

First Posted

June 14, 2017

Study Start

June 1, 2017

Primary Completion

February 15, 2018

Study Completion

March 20, 2019

Last Updated

December 30, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations